Skip to main content
. 2017 Nov;14(11):1657–1664. doi: 10.1016/j.hrthm.2017.06.012

Figure 7.

Figure 7

Effect of ranolazine (RAN) on INa recovery from inactivation. A: Recovery of INa from inactivation in atrial (filled symbols, n = 6) and ventricular (open symbols, n = 5) myocytes. Dashed lines represent fits to Supplemental Equation 4. The holding potential during recovery was −120 mV. B: Fitted fast (left-hand panel) and slow (right-hand panel) time constants in control and in the presence of 30 μM RAN for atrial (filled columns) and ventricular (open columns) myocytes. *P < .05; ***P < .001; 2-way repeated measures analysis of variance (RM ANOVA) with Bonferroni post hoc test vs control. C: Mean amplitude of slow component in control and in the presence of 30 μM RAN for atrial (filled columns) and ventricular (open columns) myocytes. *P < .05; 2-way RM ANOVA with Bonferroni post hoc test vs control.